SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MorphoSys AG (MOR)
An SI Board Since January 2000
Posts SubjectMarks Bans
421 15 0
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
271Therapeutic Antibody Program by Centocor, MorphoSys Announces Clinical MilestoneGermanecki-6/29/2009
270MorphoSys Reports Filing for Phase 1b/2a Trial for its Lead Program MOR103 in RhGermanecki-6/24/2009
269Jefferies 3rd Annual Healthcare Conference Go to webcast wsw.com Today: 3:15 pGermanecki-6/18/2009
268MorphoSys Strengthens Patent Position on its Core Technologies in Japan 06/18/20Germanecki-6/18/2009
267MorphoSys Announces Extension of Antibody Alliance with Schering-Plough 1Germanecki-6/16/2009
266MorphoSys to Present at Three Investor Conferences in June 04/06/2009 17:00:59 Germanecki-6/5/2009
265MorphoSys Achieves Clinical Milestone and Payment in Antibody Alliance 05/05/20Germanecki-5/5/2009
264MorphoSys AG Reports Strong Results for First Quarter 2009 04/28/2009 at 07:00 Germanecki-4/30/2009
263Morphosys – A Biotech Rule Breaker Morphosys (MOR.DE) is one of the most unusuaGermanecki-4/6/2009
262MorphoSys AG / Voting rights: Publication by MorphoSys AG pursuant to § 26 Germanecki-3/30/2009
261MorphoSys Strengthens Patent Position on its Core HuCAL Technology in Europe MoGermanecki-3/13/2009
260MorphoSys AG Reports Strong Financial Results for Fiscal Year 2008 02/26/2009 atGermanecki-3/6/2009
259MorphoSys Looks Externally to Grow Antibody Pipeline BioWorld International - MGermanecki-3/6/2009
258Invitation to Year End 2008 and Q4 Results Conference Call of MorphoSys AG On FeGermanecki-2/24/2009
257MorphoSys Appoints New Head of Preclinical Development 02/20/2009 at 07:30 AM MGermanecki-2/21/2009
256MorphoSys Appoints New Head of Research Antibody Business Thu. January 29, 2009Germanecki-1/29/2009
255MorphoSys to Accelerate the Expansion and Advancement of its Proprietary PipelinGermanecki-1/20/2009
254MorphoSys to Effect 1:3 Stock Split on December 23, 2008 12/19/2008 at 07:30 AMGermanecki-12/19/2008
253Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple SGermanecki-12/16/2008
252MorphoSys Announces Second Clinical Milestone in Therapeutic Antibody Program 1Germanecki-12/11/2008
251MorphoSys Appoints Dr Arndt Schottelius as Chief Development Officer and Member Germanecki-12/10/2008
250MorphoSys Unveils New Antibody Library, HuCAL PLATINUM® 12/09/2008 at 07:3Germanecki-12/9/2008
249MorphoSys Recognized as Technology Pioneer 2009 by the World Economic Forum PREGermanecki-12/5/2008
248MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic AntibodieGermanecki-11/27/2008
247That's the business of Morphosys. Generating and optimizing of the antibodieGermanecki-11/27/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News